Chemomab Therapeutics Announces Second Quarter 2022 Financial Results and Provides Corporate Update
/PRNewswire/ -- Chemomab Therapeutics, Ltd. (Nasdaq: CMMB), a clinical-stage biotechnology company focused on the discovery and development of innovative...
Source: prnewswire.com